WIN 54,461: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Bromopravadoline == | |||
[[File:6-Bromopravadoline.svg|thumb|right|Chemical structure of 6-Bromopravadoline]] | |||
'''Bromopravadoline''' is a synthetic compound that acts as a [[cannabinoid receptor]] agonist. It is primarily used in scientific research to study the [[endocannabinoid system]] and its effects on [[pain management]], [[inflammation]], and other physiological processes. | |||
== | == Chemical Properties == | ||
Bromopravadoline is a derivative of [[pravadoline]], a nonsteroidal anti-inflammatory drug (NSAID) that was initially developed for its analgesic properties. The addition of a bromine atom to the pravadoline structure enhances its affinity for cannabinoid receptors, particularly the [[CB1 receptor]]. | |||
== | == Mechanism of Action == | ||
[[ | Bromopravadoline exerts its effects by binding to and activating cannabinoid receptors in the [[central nervous system]] and [[peripheral nervous system]]. This activation leads to the modulation of neurotransmitter release, resulting in analgesic and anti-inflammatory effects. The compound's action on the CB1 receptor is similar to that of endogenous cannabinoids like [[anandamide]] and [[2-arachidonoylglycerol]]. | ||
[[ | |||
[[ | |||
== Pharmacological Effects == | |||
The primary effects of bromopravadoline include: | |||
* '''Analgesia''': By activating cannabinoid receptors, bromopravadoline can reduce the perception of pain. | |||
* '''Anti-inflammatory effects''': It can decrease inflammation by modulating immune cell activity. | |||
* '''Neuroprotection''': Some studies suggest that bromopravadoline may have neuroprotective properties, potentially beneficial in conditions like [[neurodegenerative diseases]]. | |||
== Research Applications == | |||
Bromopravadoline is used in preclinical studies to explore the therapeutic potential of cannabinoid receptor agonists. It serves as a tool to understand the role of the endocannabinoid system in various physiological and pathological processes. | |||
== Safety and Toxicology == | |||
As with many research chemicals, the safety profile of bromopravadoline is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. | |||
== Related Pages == | |||
* [[Cannabinoid receptor]] | |||
* [[Endocannabinoid system]] | |||
* [[Pravadoline]] | |||
* [[Analgesic]] | |||
* [[Nonsteroidal anti-inflammatory drug]] | |||
[[Category:Cannabinoids]] | |||
[[Category:Research chemicals]] | |||
Latest revision as of 11:32, 15 February 2025
Bromopravadoline[edit]

Bromopravadoline is a synthetic compound that acts as a cannabinoid receptor agonist. It is primarily used in scientific research to study the endocannabinoid system and its effects on pain management, inflammation, and other physiological processes.
Chemical Properties[edit]
Bromopravadoline is a derivative of pravadoline, a nonsteroidal anti-inflammatory drug (NSAID) that was initially developed for its analgesic properties. The addition of a bromine atom to the pravadoline structure enhances its affinity for cannabinoid receptors, particularly the CB1 receptor.
Mechanism of Action[edit]
Bromopravadoline exerts its effects by binding to and activating cannabinoid receptors in the central nervous system and peripheral nervous system. This activation leads to the modulation of neurotransmitter release, resulting in analgesic and anti-inflammatory effects. The compound's action on the CB1 receptor is similar to that of endogenous cannabinoids like anandamide and 2-arachidonoylglycerol.
Pharmacological Effects[edit]
The primary effects of bromopravadoline include:
- Analgesia: By activating cannabinoid receptors, bromopravadoline can reduce the perception of pain.
- Anti-inflammatory effects: It can decrease inflammation by modulating immune cell activity.
- Neuroprotection: Some studies suggest that bromopravadoline may have neuroprotective properties, potentially beneficial in conditions like neurodegenerative diseases.
Research Applications[edit]
Bromopravadoline is used in preclinical studies to explore the therapeutic potential of cannabinoid receptor agonists. It serves as a tool to understand the role of the endocannabinoid system in various physiological and pathological processes.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of bromopravadoline is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.